Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD

被引：0
|
作者：
Osunkwo, I [1 ]
Bessmertny, O [1 ]
Harrison, L [1 ]
Garvin, J [1 ]
George, D [1 ]
Bradley, MB [1 ]
DelToro, G [1 ]
Wischhover, C [1 ]
Wolownik, K [1 ]
van de Ven, C [1 ]
Cheung, YK [1 ]
Cairo, MS [1 ]
机构：
[1] Columbia Univ, New York, NY 10027 USA
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
2988
引用
收藏
页码：528A / 528A
页数：1
相关论文
共 50 条
  • [31] PHARMACOKINETICS (PK) OF IV AND PO MYCOPHENOLATE MOFETIL (MMF) IN AGE ADJUSTED PEDIATRIC AND ADOLESCENT ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS: SIGNIFICANTLY HIGHER CLss AND Vss IN PATIENTS <6 YEARS OF AGE
    Militano, O.
    Bhatia, M.
    Jin, Z.
    Figurski, M.
    Shaw, L.
    Moore, V
    Morris, E.
    Tallamy, B.
    van de Ven, C.
    Ayello, J.
    Baxter-Lowe, L. A.
    Satwani, P.
    George, D.
    Garvin, J. H.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 132 - 133
  • [32] Unrelated stem cell transplantation (SCT) following a novel reduced intensity conditioning regimen and mycophenolate mophetil (MMF) plus cyclosporin A (CsA) as graft versus host disease (GVHD) prophylaxis.
    Lacerda, JF
    Martins, C
    Carmo, JA
    Lourenco, F
    Juncal, C
    Ligeiro, D
    Martinho, A
    Lacerda, JMF
    BLOOD, 2003, 102 (11) : 430B - 430B
  • [33] Tacrolimus, Mini-Methotrexate and Mycophenolate Mofetil Is Safe and Effective as Acute Gvhd Prophylaxis for Non-Myeloablative Unrelated Donor Allogeneic Stem Cell Transplantation.
    Hong, Sanghee
    Martin, Thomas
    Damon, Lloyd E.
    Kaplan, Lawrence
    Navarro, Willis H.
    Linker, Charles
    BLOOD, 2009, 114 (22) : 481 - 481
  • [34] Graft-versus-Host Disease Prophylaxis with Tacrolimus and Mycophenolate Mofetil in HLA-Matched Nonmyeloablative Transplant Recipients Is Associated with Very Low Incidence of GVHD and Nonrelapse Mortality
    Sabry, Waleed
    Le Blanc, Richard
    Labbe, Annie-Claude
    Sauvageau, Guy
    Couban, Stephen
    Kiss, Thomas
    Busque, Lambert
    Cohen, Sandra
    Lachance, Silvy
    Roy, Denis-Claude
    Roy, Jean
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (08) : 919 - 929
  • [35] Outcomes Using Narrow Band UVB Phototherapy for Acute Skin Graft Versus Host Disease (GVHD) in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Snyder, Alan Nicholas
    Lee, Lara Wine
    Jaroscak, Jennifer Joi
    Donahoo, Lori Burton
    Hudspeth, Michelle
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [36] UNDER-EXPOSURE TO MYCOPHENOLATE ACID (MPA) AFTER REDUCED-INTENSITY CONDITIONING REGIMEN ALLOGENEIC STEM CELL TRANSPLANTATION (RIC ALLOSCT) USING MYCOPHENOLATE MOFETIL (MMF) PLUS CYCLOSPORINE A (CSA) AS GVHD PROPHYLAXIS IS ASSOCIATED TO HIGH RISK OF GRADE
    Martinez, C.
    Millan, O.
    Rovira, M.
    Fernandez-Aviles, F.
    Suarez-Lledo, M.
    Urbano-Ispizua, A.
    Brunet, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S284 - S284
  • [37] MYCOPHENOLATE MOFETIL (MMF) ADMINISTERED EVERY EIGHT HOURS WITH TACROLIMUS IS EFFICACIOUS IN ACUTE GRAFT VERSUS HOST DISEASE (aGVHD) PROPHYLAXIS IN CHILDHOOD, ADOLESCENT AND YOUNG ADULT (CAYA) ALLOGENEIC HEMATOPOIETIC PROGENITOR TRANSPLANT (ALLOHPT) RECIP
    Mehta, Brinda
    Militano, Olga
    Ozkaynak, Mehmet F.
    Van de Ven, Carmella
    Nickerson, Berkley A.
    Abrams, Debra
    Harrison, L.
    Hamby, Carl
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S97 - S97
  • [38] Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus
    Dvorak, C. C.
    Callard, E.
    Agarwal, R.
    BONE MARROW TRANSPLANTATION, 2006, 38 (03) : 253 - 254
  • [39] Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus
    C C Dvorak
    E Callard
    R Agarwal
    Bone Marrow Transplantation, 2006, 38 : 253 - 254
  • [40] Phase III study comparing tacrolimus (FK506) with cyclosporine (CSP) for prophylaxis of acute graft-versus-host disease (GVHD) after marrow transplantation from unrelated donors.
    Nash, RA
    Antin, J
    Karanes, C
    Fay, J
    Avalos, B
    Yeager, AM
    Przepiorka, D
    Davies, S
    Petersen, F
    Buell, D
    Fitzsimmons, W
    Bartels, P
    Hansen, J
    Anasetti, C
    Storb, R
    Ratanatharathorn, V
    BLOOD, 1997, 90 (10) : 2499 - 2499
12345